Canadian Pharmaceuticals & Biotech Potentially Undervalued Companies

Verano Holdings

Market Cap: CA$817.7m

Operates as a vertically integrated multi-state cannabis operator in the United States.

Decibel Cannabis

Market Cap: CA$66.3m

An integrated cannabis company, engages in the cannabis cultivation in Canada.

Planet 13 Holdings

Market Cap: CA$112.3m

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

MariMed

Market Cap: CA$42.4m

Engages in cultivation, production, and selling of branded cannabis products in the United States and internationally.

Fennec Pharmaceuticals

Market Cap: CA$257.9m

Operates as a commercial stage biopharmaceutical company in the United States.

Gilead Sciences

Market Cap: CA$149.4b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Merck

Market Cap: CA$248.9b

Operates as a healthcare company worldwide.

Medexus Pharmaceuticals

Market Cap: CA$84.6m

Operates as a pharmaceutical company in Canada and the United States.

Pfizer

Market Cap: CA$147.0b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Novo Nordisk

Market Cap: CA$1.4t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

TerrAscend

Market Cap: CA$467.0m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.

Cresco Labs

Market Cap: CA$875.1m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.

Bausch Health Companies

Market Cap: CA$2.6b

Operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally.

Delivra Health Brands

Market Cap: CA$7.2m

Through its subsidiaries, engages in the health and wellness consumer packaged goods business worldwide.

Medicure

Market Cap: CA$11.6m

A biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States.

SOL Global Investments

Market Cap: CA$3.4m

A private equity firm specializing in emerging growth.

Sanofi

Market Cap: CA$98.1b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

High Tide

Market Cap: CA$349.3m

Engages in the cannabis retail business in Canada.

Aurora Cannabis

Market Cap: CA$421.9m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

BioSyent

Market Cap: CA$133.5m

Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.

Cipher Pharmaceuticals

Market Cap: CA$354.5m

Operates as a specialty pharmaceutical company in Canada.

Novo Nordisk

Market Cap: CA$1.4t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

Thermo Fisher Scientific

Market Cap: CA$215.0b

Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.

Ayurcann Holdings

Market Cap: CA$5.8m

Provides post-harvest outsourcing solutions to licensed cannabis producers in Canada.

4Front Ventures

Market Cap: CA$4.6m

Engages in cultivating, processing, manufacturing, and sale of cannabis products in the United States.

1CM

Market Cap: CA$18.8m

Operates as a multi-jurisdictional cannabis company in Canada.

TILT Holdings

Market Cap: CA$3.9m

Provides various cannabis products and services in the United States, Canada, and internationally.

Knight Therapeutics

Market Cap: CA$602.7m

Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.

Trulieve Cannabis

Market Cap: CA$2.3b

Operates as a cannabis retailer.

Rubicon Organics

Market Cap: CA$34.3m

Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.

CordovaCann

Market Cap: CA$3.2m

Engages in the provision of services and investment capital to the processing, production, and retail vertical markets of the cannabis industry in Canada and United States.

Johnson & Johnson

Market Cap: CA$509.8b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

Christina Lake Cannabis

Market Cap: CA$9.9m

A license cannabis producer, engages in the research and development, cultivation, processing, production, and sale of cannabis in Canada.

Roche Holding

Market Cap: CA$275.3b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

InnoCan Pharma

Market Cap: CA$39.1m

A pharmaceutical technology company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Canada, Europe, and internationally.

AbbVie

Market Cap: CA$394.7b

A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.